Publication | Closed Access

Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulteration

Drug SafetyMedicinal ChemistryEmerging ThreatsPharmacologyPharmacological IssueHigh LevelsToxicologyPharmacotherapyDrug DevelopmentMedicineDrug SupplyDrug Discovery